Access Pharmaceuticals, Inc. engages in the development of polymer linked cytotoxics for use in the treatment of cancer and other diseases states utilizing proprietary delivery technologies. The company? lead product AP5346, which is in phase II clinical
- Product Details
- Brand :
- Place of Origin : Not Given
- FOB Price : On Request
- Minimum Order Quantity : Not Given
- Supply Ability :
- Packaging & Delivery
- Packaging Detail : Not Given
- Delivery Detail : Not Given
Not Given
Other Products
and then add to homescreen